Engineering tough blood clots for rapid haemostasis and enhanced regeneration. Nature 2026 May;653(8115):723-730
Date
04/30/2026Pubmed ID
42056507DOI
10.1038/s41586-026-10412-yScopus ID
2-s2.0-105037472839 (requires institutional sign-in at Scopus site) 8 CitationsAbstract
Blood clots are pivotal for haemostasis and regeneration1, but they are mechanically weak and form slowly2, posing risks for life-threatening haemorrhage and limiting broader applications3-5. These limitations are attributed to complex coagulation cascades, abundant mechanically ineffective cells and little structural polymers. Strategies that strengthen polymer networks are inapplicable to these highly cellularized materials. Here we report a strategy that rapidly crosslinks red blood cells into tough cytogels and integrates them within blood clots. The resulting engineered blood clots (EBCs) form within seconds and exhibit a 13-fold increase in fracture toughness, and a 4-fold improvement in adhesion energy compared with native clots. Experiments and modelling identify the rupture of mechanically integrated cells as a key toughening mechanism. In vivo studies demonstrate that EBCs can rapidly halt haemorrhage, promote tissue regeneration, mitigate inflammation and foreign body reactions, and prevent postoperative adhesion. The safety and efficacy of both autologous and allogeneic EBCs were also validated. Our strategy is applicable to a range of cells and polymers. This work may motivate the development and translation of highly cellularized materials for bleeding control, wound management, tissue repair and regenerative medicine.
Author List
Jiang S, Bao G, Yang Z, Wu J, Yang X, Kim JEJ, Jiang R, Zhan Y, Nottegar A, Liu Y, Gao ZH, Beckett A, Nijnik A, Long R, Kastrup C, Li JAuthor
Christian Kastrup PhD, MS Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsBlood Coagulation
Cross-Linking Reagents
Erythrocytes
Female
Hemorrhage
Hemostasis
Humans
Hydrogels
Inflammation
Male
Mice
Regeneration
Regenerative Medicine
Thrombosis
Tissue Engineering









